Actual Medicinal Product (AMP) Adempas 1mg tablets (Merck Sharp & Dohme (UK) Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible logo Medicines suitable for use in MCAs, although use is likely to be off-label.  Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed).  Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices.  Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.
Notes

No special precautions for storage.

Generic
Riociguat
Formulation
Riociguat 1mg tablets
  • Riociguat
    • Riociguat 1mg tablets

      • Adempas 1mg tablets (Merck Sharp & Dohme (UK) Ltd)